Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The focus of this study is on the understanding of the cellular interactions with polymeric drug carrier for intraarticular injection of therapeutic. The degradability of the Eupraxia’s polymeric drug carrier will be studied in contact with macrophages and/or enzymes. At each time point in the cell study the polymer surface will be characterized by SEM, and the enzymes and ROS production will be measured to compare to the control groups. The enzymatic degradation of the polymeric drug carriers will be analyzed by measuring the mass loss, Tg, surface chemistry and morphology analysis at each time point. The structure and molecular weight of the degradation products will be characterized by using NMR and MS techniques. The potential degradation mechanism will be proposed for the polymers.
Brian Amsden
Shadi Taghavi
Eupraxia Pharmaceuticals
Engineering - chemical / biological
Manufacturing
Queen's University
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.